Table 2.
Coefficients from linear regression models predicting CRP and IL-6.
Model 0 |
Model 1 |
Model 2 |
Model 3 |
Model 4 |
||||||
---|---|---|---|---|---|---|---|---|---|---|
CRP |
IL-6 |
CRP |
IL-6 |
CRP |
IL-6 |
CRP |
IL-6 |
CRP |
IL-6 |
|
Predictor | β (p) | β (p) | β (p) | β (p) | β (p) | β (p) | β (p) | β (p) | β (p) | β (p) |
Age | – | – | .11 (.029) | .41 (<.001) | .09 (.07) | .36 (<.001) | .09 (.08) | .37 (<.001) | .13 (.017) | .36 (<.001) |
Sex | – | – | .09 (.08) | -.09 (.06) | .10 (.038) | -.10 (.023) | -.09 (.048) | -.11 (.012) | .07 (.11) | -.11 (.015) |
Income | – | – | .02 (.65) | -.06 (.21) | -.01 (.83) | -.09 (.054) | -.13 (.78) | -.09 (.038) | .01 (.92) | -.09 (.055) |
Edu | – | – | -.19 (<.001) | -.11 (.021) | -.07 (.17) | .01 (.82) | -.07 (.16) | -.06 (.88) | -.08 (.11) | .01 (.87) |
Married | – | – | .05 (.29) | .03 (.52) | .03 (.45) | -.01 (.97) | .03 (.48) | .01 (.84) | .03 (.49) | -.01 (.81) |
Alcohol | – | – | – | – | -.07 (.11) | -.04 (.38) | -.07 (.11) | -.04 (.39) | -.07 (.14) | -.04 (.40) |
Smoking | – | – | – | – | .08 (.10) | .04 (.32) | .08 (.10) | .04 (.33) | .09 (.07) | .05 (.30) |
Caffeine | – | – | – | – | .04 (.32) | -.06 (.16) | .04 (.31) | -.05 (.20) | .04 (.30) | -.05 (.24) |
BMI | – | – | – | – | .43 (<.001) | .33 (<.001) | .42 (<.001) | .31 (<.001) | .44 (<.001) | .30 (<.001) |
IADL | – | – | – | – | .01 (.90) | .15 (.002) | .01 (.93) | .14 (.005) | .01 (.95) | .12 (.02) |
CESD | – | – | – | – | – | -.01 (.91) | -.01 (.83) | .07 (.17) | .01 (.88) | .08 (.13) |
Antidepr | – | – | – | – | – | – | .02 (.63) | .05 (.21) | .04 (.43) | .06 (.18) |
COX-2 | – | – | – | – | – | – | – | – | -.06 (.16) | -.01 (.83) |
NSAID oral | – | – | – | – | – | – | – | – | -.01 (.97) | .01 (.84) |
NSAID parent | – | – | – | – | – | – | – | – | -.10 (.08) | -.03 (.57) |
Statin | – | – | – | – | – | – | – | – | -.16 (<.001) | -.01 (.83) |
ACE | – | – | – | – | – | – | – | – | -.02 (.65) | .05 (.30) |
Beta block | -.02 (.64) | .06 (.15) | ||||||||
Omega-3 | .01 (.99) | -.05 (.21) | ||||||||
SNS use | .05 (.31) | -.08 (.10) | .07 (.19) | .04 (.40) | .03 (.51) | .03 (.50) | .03 (.49) | .04 (.43) | .03 (.48) | .04 (.41) |
SE | -.19 (<.001) | -.09 (.06) | -.19 (<.001) | -.16 (.001) | -.11 (.015) | -.07 (.09) | -.10 (.045) | -.04 (.48) | -.10 (.049) | -.05 (.36) |
SNS use x SE | -.12 (.011) | -.08 (.12) | -.12 (.012) | -.10 (.029) | -.09 (.048) | -.08 (.048) | -.09 (.047) | -.08 (.045) | -.09 (.031) | -.09 (.037) |
R2 | .05 | .02 | .10 | .21 | .29 | .35 | .30 | .36 | .33 | .37 |
Notes. Sex was coded with 1 (male) and 2 (female). Edu = highest degree obtained; Married = marital status (1 = married, 2 = not married, widowed, or single); Alcohol = number of drinks consumed in the past month; Smoking = cigarette smoking status (0 = never smoked, 1 = used tobacco regularly or in the past); Caffeine = number of hours since consuming caffeinated beverage; BMI = body mass index; IADL = Instrumental Activities of Daily Living; CESD = depressive symptoms; Antidepr = antidepressant medication usage; COX-2 = COX-2 inhibitor usage; NSAID oral = NSAID oral medication usage; NSAID parent = NSAID parenteral medication usage; Statin = Statin usage; ACE = Angiotensin-converting enzyme inhibitor usage; Beta block = beta-adrenergic blocker usage; Omega-3 = Omega-3 Fatty Acid usage; SNS use = amount of social media use; SE = self-esteem.